TIME FOR LIFE

INFLIMAB

Infliximab

100 mg powder for solution for infusion

  • Tumor necrosis factor alpha (TNF-α) inhibitors.
  • Chimeric human-murine monoclonal antibody to selectively block both soluble and transmembrane forms of tumor necrosis factor (TNF-α).
  • INFLIMAB used to treat a wide range of severe autoimmune diseases: rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn’s disease (active form), ulcerative colitis and psoriasis. It is usually used when other medicines or treatments have failed.
  • INFLIMAB® is the first biosimilar of Remicade® in Belarus with the identity efficacy and safety profile proven in comparative clinical studies.